Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Gombotz H et al. | Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. | 2000 | Acta Anaesthesiol Scand | pmid:10903019 |
Krafft A et al. | Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. | 2000 | Acta Obstet Gynecol Scand | pmid:10949245 |
van Iperen CE et al. | Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. | 2000 | Crit. Care Med. | pmid:10966249 |
Matsuo E et al. | Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase. | 1975 Jan-Mar | Int. J. Lepr. Other Mycobact. Dis. | pmid:1099016 |
Parkkinen J et al. | Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. | 2000 | Nephrol. Dial. Transplant. | pmid:11071973 |
Kao HH et al. | Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. | 2000 | Chang Gung Med J | pmid:11126152 |
Fishbane S and Kowalski EA | The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. | 2000 Nov-Dec | Semin Dial | pmid:11130261 |
Pollak A et al. | Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. | 2001 | Pediatrics | pmid:11134438 |
Johnson LL et al. | Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. | 2000 Nov-Dec | J Nucl Cardiol | pmid:11144474 |
Charytan C et al. | Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. | 2001 | Am. J. Kidney Dis. | pmid:11157370 |